ALM201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALM201, covering 2019-09-11 to 2019-09-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours [Phase 1]